ROI Influencers: Health Care 2024
Ken Keller
CEO & president
Daiichi Sankyo U.S.
Daiichi Sankyo is partnering with Merck in the antibody-drug conjugate space, expanding a partnership agreement the two reached in 2023.
ROI Influencers: Health Care 2024
Ken Keller
CEO & president
Daiichi Sankyo U.S.
Daiichi Sankyo is partnering with Merck in the antibody-drug conjugate space, expanding a partnership agreement the two reached in 2023.